Search Login Register
Fatigue
Summary
Description:
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
Also Known As:
Lassitude
Networked: 14059
relevant articles (1018 outcomes,
2203 trials/studies)
for this Disease
Key Drugs and Agents for Fatigue
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
modafinil (armodafinil)
:
55 outcomes 55 studies in 142 results
:
FDA 10
-
Methylphenidate (Ritalin)
:
24 outcomes 29 studies in 76 results
:
FDA 25
Generic
-
Oxygen
:
17 outcomes 33 studies in 341 results
: IBA
-
Hemoglobins (Hemoglobin)
:
15 outcomes 28 studies in 182 results
: IBA
-
ametantrone (HAQ)
:
14 outcomes 17 studies in 122 results
: IBA
-
Iron
:
13 outcomes 21 studies in 108 results
: IBA
-
Amantadine (Aman)
:
13 outcomes 21 studies in 53 results
:
FDA 20
Generic
-
Hydrocortisone (Cortisol)
:
12 outcomes 28 studies in 210 results
:
FDA 176
Generic
-
Carnitine (L-Carnitine)
:
12 outcomes 22 studies in 68 results
:
FDA 9
Generic
-
Polymethyl Methacrylate (Sol)
:
12 outcomes 21 studies in 146 results
: IBA
Show All >>
Diseases Related to Fatigue
-
Pain (Aches)
-
Neoplasms (Cancer)
-
Dyspnea (Shortness of Breath)
-
Nausea
-
Breast Neoplasms (Breast Cancer)
Show All >>
Key Therapies for Fatigue
Efficacy Chart >>
-
Drug Therapy (Chemotherapy)
:
47 outcomes 141 studies in 651 results
-
Aftercare (After-Treatment)
:
33 outcomes 23 studies in 267 results
-
Massage (Reflexology)
:
18 outcomes 20 studies in 68 results
-
Radiotherapy
:
13 outcomes 50 studies in 204 results
-
Activities of Daily Living (ADL)
:
11 outcomes 19 studies in 198 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.